New study tracks Real-World use of arthritis drug for rare blood vessel disease
NCT ID NCT07354906
First seen Jan 24, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study will follow 80 people with giant cell arteritis (GCA) that affects large blood vessels, who are taking the drug upadacitinib. Researchers will collect data from routine medical records to see how many achieve remission at 24 weeks and track relapses over two years. No extra visits or tests are required beyond normal care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHM_Hôpital La Conception
Marseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHM_Hôpital Nord
Marseille, 13915, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP_ Hôpital Pitié-Salpêtrière
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP_Hopital Lariboisière
Paris, Île-de-France Region, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP_Hôpital Bichat
Paris, Île-de-France Region, 75018, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP_Hôpital St Antoine
Paris, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH du Mans
Le Mans, France
Contact Phone: •••-•••-••••
-
CHU Caen Normandie
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Nantes - Hotel-Dieu
Nantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Rouen_Hôpital Charles Nicolle
Rouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Dijon
Dijon, France
Contact Phone: •••-•••-••••
-
Clinique Axium - Aix-en-provence
Aix-en-Provence, 13100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GHI Le Raincy Montfermeil
Montfermeil, 93370, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GHSIF Melun
Melun, 77000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.